Journal profile · ONCOLOGY-PATHOLOGY
International Journal of Clinical and Experimental Pathology
ISSN 1936-2625 · UNITED STATES · Founded 2008
International Journal of Clinical and Experimental Pathology: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 1,780; median 102 days to acceptance (97 articles, last 24 months); community-reported acceptance: about 75%; 56 articles in 2025; indexed in ESCI; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
International Journal of Clinical and Experimental Pathology is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ferroptosis and cancer prognosis, Sarcoma Diagnosis and Treatment and Cancer Immunotherapy and Biomarkers, together about 20.4% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The International Journal of Clinical and Experimental Pathology (IJCEP, ISSN 1936-2625) is an open access online journal dedicated to publication of original work in all areas of clinical, anatomic and experimental pathology. IJCEP also welcomes papers from other fields related to the study of human disease, such as immunology, biochemistry and molecular biology. IJCEP is primarily devoted to original clinical, translational and experimental research papers, but will also publish editorials, review articles, case reports, letters to the editors and meeting reports. The goal of IJCEP is to provide a free forum for rapid dissemination of clinical and basic observations that will enhance our understanding, diagnosis and management of human disease.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY-PATHOLOGY
Editor-in-chief Dennis W. DicksonPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named United States 23, Japan 13, United Kingdom 9, Germany 8, Netherlands 5 (101 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ferroptosis and cancer prognosisMedicine8.8%
- Sarcoma Diagnosis and TreatmentMedicine6.1%
- Cancer Immunotherapy and BiomarkersMedicine5.4%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.8%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.8%
- Endometrial and Cervical Cancer TreatmentsMedicine4.8%
- Glioma Diagnosis and TreatmentMedicine4.1%
- Cancer Cells and MetastasisMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCILetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2020 edition (high risk); not listed in the other 5 editions.LetPub
Indexing the journal's website claims
Web of SciencePMCPubMedPublisher website
Other: Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 43LetPub ·
- h-index
- 8OpenAlex ·
- i10-index
- 7OpenAlex ·
- 2-year mean citedness
- 1.69OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 2.14%LetPub ·
Volume
- Articles per year
- 50LetPub ·
Articles by year OpenAlex count · 204 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 32 | 48 |
| 2025 | 56 | 56 | 52 |
| 2024 | 55 | 55 | 155 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
102 daysMedian, submission to acceptance · P25–P75 76 days – 143 days
- Acceptance to online
- median 36 days (97 articles)
- Submission to online
- median 151 days
- Sample
- 97 articles with submission and acceptance dates (112 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Peer review
- Double anonymous peer review, Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 1,780 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- USD 1,780
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Reference style
- Vancouver
- Suggested reviewers
- Required, 5
- Cover letter
- Required
- Not considered
- preprints
Article types accepted5
- case reportsIJCEP is primarily devoted to original clinical, translational and experimental research papers, but will also publish editorials, review articles, case reports…Length not stated
- editorialsIJCEP is primarily devoted to original clinical, translational and experimental research papers, but will also publish editorials, review articles, case reports…Length not stated
- letters to the editorsIJCEP is primarily devoted to original clinical, translational and experimental research papers, but will also publish editorials, review articles, case reports…Length not stated
- meeting reportsIJCEP is primarily devoted to original clinical, translational and experimental research papers, but will also publish editorials, review articles, case reports…Length not stated
- review articlesIJCEP is primarily devoted to original clinical, translational and experimental research papers, but will also publish editorials, review articles, case reports…Length not stated
Policy excerpts from the journal's websitePublication ethics, License & copyright, Open access, Peer review
- Publication ethics
Complaints and ethics procedures follow COPE. Model summary
To adopt and follow reasonable procedures in the event of any complaints, ethical or otherwise, in accordance with the policies and procedures of COPE (www.publicationethics.org).
Source ↗Publisher website ·- License & copyright
Copyright transfer to publisher upon acceptance. Model summary
By submitting a manuscript to any of e-Century Publishing Corporation journal, all authors agree that all copyrights of all materials included in the submitted manuscript will be exclusively transferred to the publisher, e-Century Publishing Corporation once the manuscript is accepted.
Source ↗Publisher website ·- Open access
Open access journal with instant, worldwide, barrier-free access to full text. Model summary
International Journal of Clinical and Experimental Pathology is an open access journal which provides instant, worldwide and barrier-free access to the full-text of all published articles.
Source ↗Publisher website ·- Peer review
Peer review: all manuscripts are subject to peer review; single-blinded model generally, double-blinded protocol in case of potential conflict of interest and no other peer reviewer can be identified. Model summary
All manuscripts are subject to peer review and are expected to meet the rigorous standards of academic excellence.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Country or region
- UNITED STATES
- Founded
- 2008
- ISSN
- 1936-2625
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about International Journal of Clinical and Experimental Pathology
What CAS zone is International Journal of Clinical and Experimental Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Clinical and Experimental Pathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at International Journal of Clinical and Experimental Pathology?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 102 days (interquartile range 76–143 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of International Journal of Clinical and Experimental Pathology?
According to the journal's author guidelines: Reference style: Vancouver; Suggested reviewers: Required, 5; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of International Journal of Clinical and Experimental Pathology based?
Of the 101 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United States (23), Japan (13) and United Kingdom (9). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Clinical and Experimental Pathology?
According to LetPub and DOAJ records, International Journal of Clinical and Experimental Pathology is indexed in ESCI. The journal's website also lists Web of Science, PMC and PubMed; that list has not been checked against each database.
Is International Journal of Clinical and Experimental Pathology open access, and what is the APC?
International Journal of Clinical and Experimental Pathology is a fully open-access journal. APC about USD 1,780.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .